Remote Evaluation in Patients With Multiple Sclerosis

NCT06308042 | Not Yet Recruiting

• 1 other identifier: 2024/5558
• Study Type: observational
• Target: 10
• Locations: 0 countries
• Sites: N/A

Brief Summary

This study aimed to demonstrate the remote reliability of the 30-second sit-to-stand test in patients with multiple sclerosis.

Conditions

Multiple Sclerosis

Keywords

30 SECONDS SIT AND STAND TEST; REMOTE RELIABILITY

Outcome Measures

Primary Outcomes (1)

• 30 second sit and stand test

  The 30-second sit-to-stand test is a test used to evaluate lower extremity muscle strength, balance and walking functions.

  24-48 hours

Interventions

30 second sit and stand test OTHER

The individual sits in the middle of the chair with his back upright, his feet on the ground, and his arms crossed in front of his chest. The individual starts the test with the start command while in this position and takes off as fully as he can for 30 seconds.

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

multiple sclerosis patients

You may qualify if:

• Having been diagnosed with MS according to the McDonald criteria by a neurologist
• having and being able to use a device with Internet access (e.g. smartphone, computer or tablet)
• having EDSS between 1.5 and 6.5,
• being between the ages of 18-65.

You may not qualify if:

• Patients who have had a recurrence of the disease in the last 30 days,
• have an additional health problem (orthopedic, neurological, internal or cardiorespiratory) that prevents standing/walking,
• do not agree to participate in the study.

Sponsors & Collaborators

• Inonu University: lead

MeSH Terms

Conditions

Multiple Sclerosis

Interventions

4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNS; Autoimmune Diseases of the Nervous System; Nervous System Diseases; Demyelinating Diseases; Autoimmune Diseases; Immune System Diseases

Intervention Hierarchy (Ancestors)

Stilbenes; Benzylidene Compounds; Benzene Derivatives; Hydrocarbons, Aromatic; Hydrocarbons, Cyclic; Hydrocarbons; Organic Chemicals; Isothiocyanates; Isocyanates; Sulfur Compounds

Study Officials

• Burcu talu

  Inonu University

  STUDY DIRECTOR

Central Study Contacts

DILAN DEMİRTAŞ KARAOBA

CONTACT

0554112779; dilandemirtas92@gmail.com

: BUSRA CANDIRI

CONTACT

05073780717; candiri_17@hotmail.com

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Associate professor, physiotherapist,

Study Record Dates

• First Submitted: March 6, 2024
• First Posted: March 13, 2024
• Study Start: March 11, 2024
• Primary Completion: June 24, 2024
• Study Completion: June 29, 2024
• Last Updated: March 13, 2024

Record last verified: 2024-03

Data Sharing

• IPD Sharing: Will share
• Shared Documents: STUDY PROTOCOL, SAP, CSR
• Time Frame: After the study was published
• Access Criteria: If requested from the authors, it can be shared with researchers at the authors' discretion.